9. Net Income (Loss) Per Share (as restated)

The following table summarizes the computation of the basic and diluted net income (loss) per share:

Summary of Basic and Diluted Net Loss Per Common Share 

The following table summarizes the outstanding warrants provision to participate in distribution of earnings. For the three months ended March 31, 2025 and 2026, these securities were excluded in the calculation for distribution of net loss but included in the allocation of undistributed earnings:

Schedule of Allocation of Undistributed Earnings

The following table summarizes the outstanding potentially dilutive securities that have been excluded in the calculation of diluted net loss per share because their inclusion would be anti-dilutive:

Summary of Outstanding Potentially Dilutive Securities 

The potential dilutive common stock options are options granted under the Company’s 2019 Equity Plan and 2021 Equity Plan were excluded from the calculation of diluted earnings per share and weighted average shares of Common Stock outstanding, as each of them had an exercise price that exceeded the average market price of the Company’s Common Stock during the period.

The potentially dilutive common stock warrants are (1) warrants to purchase up to 21,099 shares of Common Stock at $156.00 per share, (2) warrants to purchase up to 412,882 shares of Common Stock at $3.633 per share (subject to stockholder approval) and (3) warrants to purchase up to 503,402 shares of Common Stock at $14.46 per share, which may be amended, subject to stockholder approval, to reduce the exercise price to $3.633 per share. These Common Stock Warrants each had an exercise price that exceeded the closing price of the Company’s Common Stock as of March 31, 2026, and were excluded from the calculation of diluted earnings per share and weighted average shares of Common Stock outstanding.